Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cue Health Inc (NQ: HLTH )

0.0990 -0.0080 (-7.48%)
Streaming Delayed Price Updated: 2:02 PM EDT, May 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cue Health Inc

< Previous 1 2 3 4 5 6 Next >
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Cue Health: Q3 Earnings Insights
Via Benzinga
Cue Health Reports Third Quarter 2023 Financial Results
From Cue Health Inc.
Via Business Wire
Cue Health to Announce Third Quarter 2023 Financial Results
From Cue Health Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Independent Clinical Study Confirms Cue Health’s COVID-19 Test Is As Accurate As a Lab Test
--News Direct-- 
Via News Direct
Exposures COVID-19 Product Safety
Independent Clinical Study Confirms Cue Health's COVID-19 Test Is As Accurate As A Lab Test
A new study published in Microbiology Spectrum put Cue Health’s (NASDAQ: HLTH) COVID 
Via Benzinga
Exposures COVID-19
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Concerned Stockholders of Cue Health Send Letter to Board
From On behalf of Concerned Stockholders of Cue Health
Via Business Wire
Peer-Reviewed Independent Study Published in Microbiology Spectrum Finds Cue Health’s Molecular COVID-19 Test is as Accurate as a Lab-Based PCR Test
From Cue Health
Via Business Wire
Cue Health Adopts Limited-Duration Shareholder Rights Plan
From Cue Health Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Why Lands' End Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Acer Therapeutics Inc. (NASDAQ: ACER) shares jumped 145% to $1.4850 after Zevra Therapeutics announced it will acquire the company. The transaction will have a total potential value for Acer... 
Via Benzinga
Cue Health to Present at Upcoming Investor Conferences
From Cue Health Inc.
Via Business Wire
This Healthcare Tech Company Has Become The First To Receive FDA De Novo Authorization For An OTC COVID-19 Test
--News Direct-- 
Via News Direct
Exposures COVID-19 Product Safety
This Healthcare Tech Company Has Become The First To Receive FDA De Novo Authorization For An OTC COVID-19 Test
The healthcare technology company Cue Health Inc. (NASDAQ: HLTH) has become the first company to get De Novo authorization from the U.S. 
Via Benzinga
Exposures COVID-19 Product Safety
Cue Health Reports Second Quarter 2023 Financial Results
From Cue Health Inc.
Via Business Wire
Cue Health Awarded New $28 Million Federal Contract to Develop Flu A/B, RSV, COVID-19 Molecular Multiplex Test for Both Over-the-Counter and Point-of-Care Use
From Cue Health Inc.
Via Business Wire
Cue Health to Announce Second Quarter 2023 Financial Results
From Cue Health Inc.
Via Business Wire
Cue Health’s Growing Integrated Care Platform Of Lab-Quality Diagnostic Tests For Use At-Home And At The Point-of-Care Is Transforming How Healthcare Is Delivered
--News Direct-- 
Via News Direct
Exposures COVID-19 Product Safety
Cue Health's Growing Integrated Care Platform Of Lab-Quality Diagnostic Tests For Use At-Home And At The Point-of-Care Is Transforming How Healthcare Is Delivered
Last month, the Food and Drug Administration (FDA) granted a landmark De Novo authorization for Cue Health’s (NASDAQ: HLTH) at-home COVID-19 test that 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Cue Health Becomes First Company to Receive FDA De Novo Authorization COVID-19 Home Use Test
Cue Health Inc (NASDAQ: HLTH) became the first company to receive De Novo authorization from the FDA for its Cue COVID-19 Molecular Test, designed for both home and  
Via Benzinga
Cue Health Achieves Groundbreaking Milestone with FDA: First Company to Receive De Novo Authorization for a COVID-19 Home Use Test
From Cue Health
Via Business Wire
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 69 stocks hit new 52-week lows. 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.